Trial NCT04267939

View at ClinicalTrials.gov 
Org. Study IDs: 18595
Secondary IDs: 2018-003930-34

Last trial update was posted on 2023-12-21

MeSH Interventions

Niraparib

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Advanced Solid Tumors (Excluding Prostate Cancer) Ovarian Cancer

Stopping Reasons

There was no anticipated benefit of the experimental combination as tested over available standard therapies; therefore Sponsor has decided to terminate the investigation.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID